Breaking News Instant updates and real-time market news.

MYL

Mylan

$31.79

-0.21 (-0.66%)

, XRAY

Dentsply Sirona

$61.41

-0.93 (-1.49%)

20:25
08/08/17
08/08
20:25
08/08/17
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Mylan (MYL), consensus $1.16... DENTSPLY SIRONA (XRAY), consensus 65c... Scripps Networks Interactive (SNI), consensus $1...US Foods (USFD), consensus 37c... Charles River Laboratories (CRL), consensus $1.22... Wendy's (WEN), consensus 13c... Tribune Media (TRCO), consensus 41c... Office Depot (ODP), consensus 8c... Children's Place (PLCE), consensus 75c.

MYL

Mylan

$31.79

-0.21 (-0.66%)

XRAY

Dentsply Sirona

$61.41

-0.93 (-1.49%)

SNI

Scripps Networks

$87.80

0.14 (0.16%)

USFD

US Foods

$28.61

0.14 (0.49%)

CRL

Charles River

$98.36

-1.24 (-1.25%)

WEN

Wendy's

$15.22

-0.25 (-1.62%)

TRCO

Tribune Media

$40.87

0.28 (0.69%)

ODP

Office Depot

$6.11

-0.06 (-0.97%)

PLCE

Children's Place

$118.00

3.55 (3.10%)

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

  • 15

    Aug

  • 03

    Sep

  • 09

    Oct

MYL Mylan
$31.79

-0.21 (-0.66%)

07/18/17
WELS
07/18/17
NO CHANGE
WELS
Market Perform
Novartis report has cautious read-through for Mylan, Teva, says Wells Fargo
Wells Fargo analyst David Maris noted that Novartis' (NVS) Sandoz unit is one of the world's largest generic drug makers and he believes the proper read-through from its report is that the U.S. generic market remains challenging and that investors should remain cautious on the generics space. Maris, who said he would not be surprised to see Mylan (MYL) or Teva (TEVA) weaker following Novartis' report, keeps Market Perform ratings on those two names.
06/12/17
SBSH
06/12/17
NO CHANGE
Target $38
SBSH
Buy
Citi says CRL for Coherus not worst case scenario
Citi analyst Mohit Bansal says Coherus Biosciences' (CHRS) complete response letter for its biosimilar version of Neulasta, while "clearly a negative outcome," is not the worst case scenario since the FDA did not ask for another study. The analyst sees a one year delay, which impacts his discounted free cash flow model by $5 per share. Coherus in premarket trading is down 30%, or $6.25, to $14.40. A one year delay would mean Coherus' CHS-1701 could still be on markets at the same time as competition from Mylan (MYL) and ahead of Sandoz's approval in 2019, Bansal tells investors in a research note. The analyst has a Buy rating on Coherus with a $38 price target.
06/16/17
CANT
06/16/17
INITIATION
Target $41
CANT
Neutral
Mylan initiated with a Neutral at Cantor
Cantor Fitzgerald analyst Louise Chen started Mylan with a Neutral rating and $41 price target.
06/21/17
WELS
06/21/17
NO CHANGE
WELS
Market Perform
Wells wouldn't be surprised to see greater scrutiny on Mylan coal tax credits
After a new report from Reuters questioned the way in which Mylan uses its ownership of coal processing plants to keep its taxes low, Wells Fargo analyst David Maris said this topic has interested him for some time but his questions to management on the issue were not answered. Maris, who said he would not be surprised to see greater public scrutiny on this issue after the report, keeps a Market Perform rating on Mylan shares.
XRAY Dentsply Sirona
$61.41

-0.93 (-1.49%)

07/11/17
HCWC
07/11/17
INITIATION
Target $74
HCWC
Buy
Dentsply Sirona initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Dentsply Sirona with a Buy rating and $74 price target. The analyst like the company's diversification and "sustainable" cash flows.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $75
FBCO
Outperform
Dentsply Sirona price target raised to $75 from $67 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Dentsply Sirona to $75 from $67 as the company adjusts its third-party distribution strategy in North America and continues to find opportunities to deploy its cash flow in an accretive fashion. The analyst reiterates an Outperform rating on the shares.
07/26/17
GSCO
07/26/17
NO CHANGE
GSCO
Dental survey indicates Q2 upside for Align, Henry Schein, says Goldman Sachs
Goldman analyst Robert Jones said checks indicate Q2 Dental trends remained stable and point to consistent low-single-digit growth end-markets. The analyst likes Align Technology (ALGN) saying Q2 case guidance appears beatable and expects high 20% case growth driven by investments, sees Q2 upside for Henry Schein (HSIC) due to share gains from Patterson Companies (PDCO), and said Dentsply Sirona (XRAY) promotions to drive cross-selling have yet to gain traction and 2017 guidance may be aggressive, but expectations are low into the quarter.
08/01/17
NRCS
08/01/17
NO CHANGE
Target $76
NRCS
Buy
Dentsply Sirona estimaters reduced at Northcoast
Northcoast analyst Ed Snyder's checks indicate Patterson Companies (PDCO) sales of high technology dental equipment is weaker than expected caused by industry competition. Snyder said it appears Patterson's CEREC sales growth is down about 40-50%, despite promotional activity. As a result, he reduced Dentsply Sirona's (XRAY) second half internal growth estimate to 1.4% from 2.3% and earnings FY17 earnings estimate to $2.80 from $2.82. Snyder retains a Buy rating on Dentsply and a $76 price target.
SNI Scripps Networks
$87.80

0.14 (0.16%)

08/08/17
PIVT
08/08/17
UPGRADE
Target $28
PIVT
Buy
Discovery upgraded to Buy after post-Scripps deal weakness at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Discovery (DISCA) to Buy from Hold in light of the stock's recent weakness following its deal to acquire Scripps Networks (SNI). While the "advantages of this combination should not be overstated," Wieser expects that a combined company may perform slightly better in the national TV upfront markets and he notes the guidance for $350M in annual cost synergies after 2019. Wieser keeps a $28 price target on Discovery shares, which have declined about 9.5% since July 31, the day the company confirmed its deal to buy Scripps.
08/01/17
ARGS
08/01/17
DOWNGRADE
ARGS
Hold
Scripps Networks downgraded to Hold from Buy at Argus
Argus analyst Joseph Bonner downgraded Scripps (SNI) following its acquisition by Discovery Communications (DISCA).
08/01/17
SBSH
08/01/17
UPGRADE
SBSH
Neutral
Scripps Networks upgraded to Neutral from Sell at Citi
Citi analyst Jason Bazinet upgraded Scripps Networks (SNI) to Neutral following its acquisition by Discovery Communications (DISCA). The analyst this morning also upgraded Discovery to Buy.
08/01/17
SBSH
08/01/17
UPGRADE
Target $29
SBSH
Buy
Discovery upgraded to Buy from Neutral at Citi
Citi analyst Jason Bazinet upgraded Discovery Communications (DISCA) to Buy with a $29 price target. The analyst views the acquisition of Scripps Networks (SNI) as "not that bad of a deal."
USFD US Foods
$28.61

0.14 (0.49%)

08/08/17
WELS
08/08/17
NO CHANGE
WELS
Food distributors outlook positive into June quarter results, says Wells Fargo
Wells Fargo says that sentiment on the food distributors has deteriorated due to worries about inflation and Amazon's (AMZN)possible entry into the space. However, the firm thinks that inflation is "a net positive" for the sector, while the three largest companies in the sector look set to benefit from share gains and M&A accretion. Wells is most upbeat on US Foods (USFD)and Sysco (SYY), citing reductions in their valuation and their efforts to increase volume and margins. Wells thinks the stocks have reached attractive entry points as it believes that investors are exaggerating the Amazon threat. It keeps Outperform ratings on US Foods and Sysco.
06/26/17
GUGG
06/26/17
NO CHANGE
GUGG
Food distributor decline 'seems overdone,' says Guggenheim
Guggenheim analyst John Heinbickel says that the decline of food distributors in the wake of Amazon's (AMZN) acquisition of Whole Foods (WFM) "seems overdone." The analyst thinks the notion that Amazon will look to enter the food distribution business is "highly unlikely...especially in the near to intermediate term". He says that such an initiative would require "a separate, dedicated supply chain as well as a field-level sales force," both of which would be "challenging" to launch. The analyst adds that customers in the sector have "inertia," especially vis-a-vis fresh food. He recommends buying food distributors Performance Food Group (PFGC) and US Foods (USFD) on weakness.
06/16/17
RBCM
06/16/17
NO CHANGE
RBCM
Amazon deal shouldn't directly hurt foodservice distributors, says RBC Capital
RBC Capital said Amazon's (AMZN) deal for Whole Foods (WFM) should not have a direct negative impact on foodservice distributors such as Sysco (SYY), US Foods (USFD) and Performance Food Group (PFGC), noting that there is not enough dock space at Whole Foods to help the e-commerce giant service restaurant needs, though they do acknowledge that combo may take a "small share" from restaurant occasions.
06/07/17
FBCO
06/07/17
NO CHANGE
FBCO
US Foods removed from U.S. Focus List at Credit Suisse
Credit Suisse removed U.S. Foods from its U.S. Focus List citing the departure of the primary analyst.
CRL Charles River
$98.36

-1.24 (-1.25%)

01/04/17
01/04/17
UPGRADE
Target $86.5

Buy
Charles River upgraded to Buy on robust demand, earnings growth at Evercore ISI
As previously reported, Evercore ISI upgraded Charles River to Buy from Hold and with an $86.50 price target. Analyst Ross Muken said his upgrade hinges on three key items, robust biopharma demand is likely to continue and benefit discovery/early development, fears of margin degradation from a mix shift are overblown, and management has a stellar capital allocation track record that has led to significant TSR. Muken adds Charles River's current discount provides a favorable entry point for investors looking for upside from double digit earnings growth.
02/15/17
BARD
02/15/17
NO CHANGE
Target $100
BARD
Outperform
Charles River price target raised to $100 from $89 at Baird
Baird analyst Eric Coldwell raised his price target on Charles River Labs to $100 from $89 as he said the company is firing on all cylinders. He believes the shares have room to run as the valuation is not stretched and secular trends and catalysts are ahead. Coldwell reiterated his Outperform rating on Charles River shares.
05/12/17
RHCO
05/12/17
NO CHANGE
RHCO
Charles River weakness unjustified, says SunTrust
SunTrust analyst Sandy Draper believes that Charles River reported "solid" results.He thinks investors are worried that the company's lower than expected Discovery and Safety Assessment revenue "indicates a cycle top for early-stage research." The analyst disagrees with this assessment ,partly because of the company's "rapidly accelerating bookings growth in March." He thinks the stock's weakness has created a good buying opportunity and keeps a $105 price target on the name.
02/14/17
BARD
02/14/17
NO CHANGE
Target $100
BARD
Outperform
Charles River price target raised to $100 from $89 at Baird
Baird analyst Eric Coldwell raised Charles River's price target to $100 following the Q4 beat and guidance. Coldwell reiterates his Outperform rating and said valuation isn't stretched and secular trends and catalysts are favorable.
WEN Wendy's
$15.22

-0.25 (-1.62%)

05/11/17
SPHN
05/11/17
NO CHANGE
Target $18
SPHN
Overweight
Wendy's price target raised to $18 from $16 at Stephens
Stephens analyst Will Slabaugh said he continues to be impressed by the top-line consistency at Wendy's, which he credits to the continued success of its value offerings and marketing. The analyst, who sees the company winning at both the value and premium ends of the menu, raised his price target on Wendy's to $18 from $16 following its Q1 report and keeps an Overweight rating on the shares.
05/11/17
RHCO
05/11/17
NO CHANGE
RHCO
Wendy's price target raised to $18 from $16 at SunTrust
SunTrust analyst Jake Bartlett continues to expect Wendy's stock to rise, driven by SSS outperformance, new restaurants, and cost cutting. The analyst noted that the company's SSS rose 1.6%, outperforming peers excluding McDonald's (MCD) SSS gain of 0.4%. Bartlett expects the company to continue to do well in 2H17 and he keeps a Buy rating on the shares.
04/21/17
BMOC
04/21/17
INITIATION
Target $17
BMOC
Outperform
Wendy's initiated with an Outperform at BMO Capital
BMO Capital analyst Andrew Strelzik initiated Wendy's with an Outperform and a $17 price target. The analyst views Wendy's as attractive opportunity given its more defensible premium positioning, strong visibility into achieving long-term targets after structural business model enhancements, and discounted valuation.
04/21/17
04/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Plains All American (PAA) initiated with an Outperform at Macquarie. 2. Wendy's (WEN) and McDonald's (MCD) were initiated with an Outperform at BMO Capital while Yum! Brands (YUM) was initiated with a Market Perform. 3. Cedar Fair (FUN), Six Flags (SIX), and SeaWorld (SEAS) were initiated with a Buy at Stifel. 4. Domino's Pizza (DPZ) initiated with a Buy at Guggenheim. 5. Cidara Therapeutics (CDTX) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TRCO Tribune Media
$40.87

0.28 (0.69%)

08/08/17
BNCH
08/08/17
NO CHANGE
BNCH
Buy
Fox-ION 'rumors' most likely a negotiating tactic, says Benchmark
Benchmark analyst Daniel Kurnos highlighted a "slew" of "inconsistencies" that make him skeptical of last week's "unsubstantiated rumor published by Bloomberg" regarding Fox (FOXA) potentially forming a JV with ION and pulling all of its affiliate agreements from Sinclair (SBGI), concluding in a note to investors that this was "just another negotiating tactic by the network." Fox's "cozy" agreements with Tribune (TRCO) may get disrupted by Sinclair's acquisition, added Kurnos, who has a Buy rating on Sinclair shares.
06/02/17
SPHN
06/02/17
NO CHANGE
SPHN
Overweight
Regulatory uncertainty may cause volatility for Sinclair, Tribune, says Stephens
Stephens analyst Kyle Evans noted that a federal court has temporarily delayed effectiveness of the FCC's decision to reinstate the UHF discount, which he said is critical for Sinclair Broadcast's (SBGI) deal to acquire Tribune Media (TRCO). The deal could be jeopardized if the court permanently blocked the UHF discount and regulatory uncertainty may cause volatility in the stocks, said Evans. The analyst reiterates his Overweight rating and $46 price target on Sinclair shares.
05/12/17
WELS
05/12/17
NO CHANGE
WELS
Sinclair Broadcast 'weakness completely unwarranted,' says Wells Fargo
After Sinclair (SBGI) announced that it had agreed to buy Tribune Media (TRCO) on May 8 and Tribune's stock fell over 5% since then, Wells Fargo calls Tribune's weakness "completely unwarranted." The firm says that the deal is significantly accretive to Sinclair's free cash flow. It adds that Sinclair is outperforming its peers in advertising ,while its leverage could drop to four times by 2018. Wells keeps an Outperform rating on Sinclair.
05/08/17
WELS
05/08/17
NO CHANGE
WELS
Outperform
Wells Fargo likes Sinclair's acquisition of Tribune Media
Wells Fargo analyst Marci Ryvicker likes Sinclair Broadcast's acquisition of Tribune Media (TRCO). The deal was done at a "very attractive" multiple and is "clearly accretive" to free cash flow, Ryvicker tells investors in a research note. Applying 40% of free cash flow accretion per share, the analyst arrives at a "fair market value" price for Sinclair of $55 per share. The stock in early trading is up $1.12 to $38.08.
ODP Office Depot
$6.11

-0.06 (-0.97%)

07/31/17
LOOP
07/31/17
NO CHANGE
LOOP
Hold
Loop struggles to see long-term rationale for Office Depot buying Staples stores
After the New York Post said Staples (SPLS) has held talks to sell its 1,500 North American retail stores to Office Depot (ODP), Anthony Chukumba said he believes buying the stores would result in significant synergies for Office Depot and could make near-term sense, but he has a hard time understanding the long-term strategic rationale to "double down" on the secularly declining retail business. Any short-term benefits would be more than offset by the negative long-term implications, believes Chukumba, who keeps a Hold rating on Office Depot shares.
07/12/17
LOOP
07/12/17
NO CHANGE
LOOP
Hold
Office Depot LBO potential doesn't offer significant upside, says Loop Capital
After the recent agreement struck by Staples (SPLS) to go private, Loop Capital analyst Anthony Chukumba examined the leveraged buyout potential of peer Office Depot (ODP). He estimates that a takeover by a private equity sponsor at $7 per share would generate "acceptable, but not awesome" returns, which he concludes provides some level of downside protection but not a significant amount of upside potential for Office Depot shares. Chukumba keeps a Hold rating on Office Depot.
04/04/17
KEYB
04/04/17
NO CHANGE
KEYB
Staples would be of interest to PE buyers, says KeyBanc
Following The Wall Street Journal report that Staples (SPLS) is exploring a sale and holding talks with possible private equity bidders, KeyBanc analyst Bradley Thomas said he believes the company would be of interest given its strong free cash flow generation and recent actions taken to make its operations more streamlined. Additionally, the rise of Amazon's (AMZN) delivery segment could provide the "silver lining" of making another attempt at a combination of Staples and Office Depot (ODP) possible, Thomas tells investors.
01/30/17
LOOP
01/30/17
NO CHANGE
LOOP
Hold
Loop says Office Depot CEO pick positive, but doesn't change fundamentals
Loop Capital analyst Anthony Chukumba said he views Office Depot's appointment of Gerry Smith as CEO as a positive given his strong technology background and the fact that the hiring reduces senior management uncertainty. However, this one appointment does not eliminate management uncertainty completely and does not change the company's fundamental outlook, said Chukumba, who keeps a Hold rating on the shares.
PLCE Children's Place
$118.00

3.55 (3.10%)

06/26/17
TLSY
06/26/17
UPGRADE
TLSY
Outperform
Children's Place upgraded to Outperform from Market Perform at Telsey Advisory
06/09/17
06/09/17
NO CHANGE
Target $127

Outperform
Children's Place selloff a 'significant' buying opportunity, says FBR Capital
FBR Capital analyst Susan Anderson views the 14% pullback over the past month in shares of Children's Place as a "significant" buying opportunity. The analyst calls her recent meetings with company management "very positive." The meetings supported the analyst's belief that Children's Place "is in a league of its own given" given the company's internal initiatives as well as a "more stable" children's sector. Anderson expects the stock will continue to outperform over the next several years and reiterates an Outperform rating on the name with a $127 price target.
05/22/17
MSCO
05/22/17
NO CHANGE
Target $150
MSCO
Overweight
Children's Place price target raised to $150 from $140 at Morgan Stanley
Morgan Stanley analyst Jay Sole raised Children's Place's price target to $150 and increased his FY17 base case earnings estimate to $7.25, versus consensus of $6.85, and FY18 earnings estimate to $8, versus consensus of $7.50, following the Q1 report. The analyst said the average leases life is below 3 years, 54% of Children's Place stores have a Justice within a one mile radius, eComm business is EBIT margin accretive, and wholesale and international businesses are gaining traction. Sole rates shares an Overweight.
04/19/17
04/19/17
NO CHANGE

Outperform
Children's Place selloff a 'significant' buying opportunity, says FBR Capital
FBR Capital analyst Susan Anderson views the 12% pullback in shares of Children's Place since the March peak as a "significant" buying opportunity. The stock pulled back yesterday after MScience said the company's comp sales were running down low-single-digits at March-end, Anderson tells investors in a research note. She believes Children's Place's Q1 same-store-sales will "easily" be in line with the positive low-single-digit guidance, if not better, even if sales turned negative at the end of March. Channel checks continue to be positive with promos flattish year-over-year and in-store clearance very lean, the analyst writes. She keeps an Outperform rating on Children's Place.

TODAY'S FREE FLY STORIES

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/23/18
09/23
04:55
09/23/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.